US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist
  • 31.130
  • +1.900+6.50%
Close Nov 27 16:00 ET
  • 31.130
  • 0.0000.00%
Post 20:01 ET
3.17BMarket Cap-8695P/E (TTM)

Dyne Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
69.67%105.66M
7.83%71.96M
52.11%69.16M
41.65%242.16M
68.61%67.69M
47.29%62.27M
26.50%66.74M
27.05%45.46M
13.96%170.96M
-22.74%40.15M
Selling and administrative expenses
83.12%12.86M
27.52%9.7M
210.52%24.62M
11.34%31.4M
27.16%8.84M
-7.71%7.02M
24.87%7.61M
5.05%7.93M
-1.79%28.2M
-27.99%6.96M
-General and administrative expense
83.12%12.86M
27.52%9.7M
210.52%24.62M
11.34%31.4M
27.16%8.84M
-7.71%7.02M
24.87%7.61M
5.05%7.93M
-1.79%28.2M
-27.99%6.96M
Research and development costs
67.96%92.8M
5.30%62.26M
18.66%44.54M
47.63%210.76M
77.29%58.84M
59.36%55.25M
26.71%59.13M
32.94%37.54M
17.68%142.76M
-21.54%33.19M
Operating profit
-69.67%-105.66M
-7.83%-71.96M
-52.11%-69.16M
-41.65%-242.16M
-68.61%-67.69M
-47.29%-62.27M
-26.50%-66.74M
-27.05%-45.46M
-13.96%-170.96M
22.74%-40.15M
Net non-operating interest income expense
323.76%9.28M
219.53%7.05M
101.07%3M
161.95%7.64M
30.48%1.75M
142.41%2.19M
400.45%2.21M
549.13%1.49M
293.13%2.92M
637.36%1.34M
Non-operating interest income
323.76%9.28M
219.53%7.05M
101.07%3M
161.95%7.64M
30.48%1.75M
142.41%2.19M
400.45%2.21M
549.13%1.49M
293.13%2.92M
637.36%1.34M
Other net income (expense)
-488.89%-742K
48.53%-192K
334.26%506K
-2,522.22%-1.42M
-2,820.83%-701K
-1,300.00%-126K
-3,830.00%-373K
-620.00%-216K
-575.00%-54K
-24K
Other non- operating income (expenses)
-488.89%-742K
48.53%-192K
334.26%506K
-2,522.22%-1.42M
-2,820.83%-701K
-1,300.00%-126K
-3,830.00%-373K
-620.00%-216K
-575.00%-54K
---24K
Income before tax
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
Income tax
Net income
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
Net income continuous Operations
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
Minority interest income
Net income attributable to the parent company
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
Basic earnings per share
3.03%-0.96
35.19%-0.7
-3.85%-0.81
-22.29%-3.95
-47.30%-1.09
-23.75%-0.99
-6.93%-1.08
-13.04%-0.78
-10.24%-3.23
26.00%-0.74
Diluted earnings per share
3.03%-0.96
35.19%-0.7
-3.85%-0.81
-22.29%-3.95
-47.30%-1.09
-23.75%-0.99
-6.93%-1.08
-13.04%-0.78
-10.24%-3.23
26.00%-0.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 69.67%105.66M7.83%71.96M52.11%69.16M41.65%242.16M68.61%67.69M47.29%62.27M26.50%66.74M27.05%45.46M13.96%170.96M-22.74%40.15M
Selling and administrative expenses 83.12%12.86M27.52%9.7M210.52%24.62M11.34%31.4M27.16%8.84M-7.71%7.02M24.87%7.61M5.05%7.93M-1.79%28.2M-27.99%6.96M
-General and administrative expense 83.12%12.86M27.52%9.7M210.52%24.62M11.34%31.4M27.16%8.84M-7.71%7.02M24.87%7.61M5.05%7.93M-1.79%28.2M-27.99%6.96M
Research and development costs 67.96%92.8M5.30%62.26M18.66%44.54M47.63%210.76M77.29%58.84M59.36%55.25M26.71%59.13M32.94%37.54M17.68%142.76M-21.54%33.19M
Operating profit -69.67%-105.66M-7.83%-71.96M-52.11%-69.16M-41.65%-242.16M-68.61%-67.69M-47.29%-62.27M-26.50%-66.74M-27.05%-45.46M-13.96%-170.96M22.74%-40.15M
Net non-operating interest income expense 323.76%9.28M219.53%7.05M101.07%3M161.95%7.64M30.48%1.75M142.41%2.19M400.45%2.21M549.13%1.49M293.13%2.92M637.36%1.34M
Non-operating interest income 323.76%9.28M219.53%7.05M101.07%3M161.95%7.64M30.48%1.75M142.41%2.19M400.45%2.21M549.13%1.49M293.13%2.92M637.36%1.34M
Other net income (expense) -488.89%-742K48.53%-192K334.26%506K-2,522.22%-1.42M-2,820.83%-701K-1,300.00%-126K-3,830.00%-373K-620.00%-216K-575.00%-54K-24K
Other non- operating income (expenses) -488.89%-742K48.53%-192K334.26%506K-2,522.22%-1.42M-2,820.83%-701K-1,300.00%-126K-3,830.00%-373K-620.00%-216K-575.00%-54K---24K
Income before tax -61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M
Income tax
Net income -61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M
Net income continuous Operations -61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M
Minority interest income
Net income attributable to the parent company -61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M
Basic earnings per share 3.03%-0.9635.19%-0.7-3.85%-0.81-22.29%-3.95-47.30%-1.09-23.75%-0.99-6.93%-1.08-13.04%-0.78-10.24%-3.2326.00%-0.74
Diluted earnings per share 3.03%-0.9635.19%-0.7-3.85%-0.81-22.29%-3.95-47.30%-1.09-23.75%-0.99-6.93%-1.08-13.04%-0.78-10.24%-3.2326.00%-0.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data